News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Avexa Limited (AVX.AX) Secures CCR5 Inhibitor HIV Program With TargetDrug


4/18/2007 1:24:49 PM

VICTORIA, Australia--(BUSINESS WIRE)--Avexa (ASX:AVX) today announced the completion and formalisation of the licensing and collaboration agreement on a CCR5 HIV drug program with TargetDrug of Shanghai on terms as announced on 4 December 2006. Avexa and TargetDrug have already commenced the collaborative phase of the agreement aimed at the identification of new and improved clinical candidates from the program.

Read at BioSpace.com


comments powered by Disqus
   
HIV/AIDS

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES